Hepatobiliary & Pancreatic Diseases International

Papers
(The H4-Index of Hepatobiliary & Pancreatic Diseases International is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Palmar metastasis of hepatocellular carcinoma: An uncommon case report42
Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas mimicking pancreatic pseudocyst38
Relevant content37
Primary pancreatic lymphoma diagnosed by endoscopic ultrasound-guided fine needle biopsy36
Inadvertent perioperative hypothermia and surgical site infections after liver resection35
Meetings and Courses33
Laparoscopic extended right hepatectomy for posterior and completely caudate massive liver tumor (with videos)33
CK2α causes stemness and chemotherapy resistance in liver cancer through the Hedgehog signaling pathway32
Impact of metabolic disorders on gallstone disease and perioperative recovery after laparoscopic cholecystectomy31
Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidence30
Cryptococcosis in patients with liver cirrhosis: Death risk factors and predictive value of prognostic models28
Advances and current research status of early diagnosis for gallbladder cancer27
Application of extended criteria donor liver grafts in liver transplantation26
Pre-MASLD: Should it be defined separately?25
Post-hepatectomy liver failure: A timeline centered review23
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study22
Minimizing the risk of small-for-size syndrome after liver surgery21
The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional s20
Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach19
0.071478128433228